Madrigal Pharmaceuticals Inc


Market Cap$4.39B

Compare Madrigal Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Madrigal Pharmaceuticals IncMadrigal Pharmaceuticals Inc00%---
marketMarket Avg49.51.28%13%6.20.1
HealthcareHealthcare Avg31.91.26%18%7.50.9

Current Fair Value

6.7% downside

Overvalued by 6.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.39 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares19,742,646
Avg 30 Day Volume584,827


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Madrigal Pharmaceuticals Inc

CEO: Rebecca Taub